Sec. 1. Short title; table of contents

162 words·~1 min read·/bill/119/s/4189/is/section-1

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

This Act may be cited as the or the Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 . INSULIN Act of 2026 The table of contents for this Act is as follows: Sec. 1. Short title; table of contents. Sec. 2. Sense of Congress. TITLE I—Commercial market patient protections Sec. 101. Requirements with respect to cost-sharing for certain insulin products. Sec. 102. Application to retiree and certain small group plans. Sec. 103. Administration. TITLE II—Pharmacy benefit manager transparency and rebate reform Sec. 201.

Full rebate on insulin pass-through to plan. TITLE III—Biosimilar biological product and generic drug competition and affordability Sec. 301. Ensuring timely access to generics. Sec. 302. Expediting competitive biosimilar competition. Sec. 303. Insulin competition report. TITLE IV—Programs for providing affordable insulin to uninsured individuals Sec. 401. Pilot program for providing affordable insulin to uninsured individuals. Sec. 402. GAO study on uninsured individuals who use insulin.

Sec. 403. Insulin resource center and hotline for uninsured individuals.